Tanayama S - Search Results

1

Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys.

Maeshiba Y, Kiyota Y, Yamashita K, Yoshimura Y, Motohashi M, Tanayama S. Maeshiba Y, et al. Among authors: tanayama s. Arzneimittelforschung. 1997 Jan;47(1):29-35. Arzneimittelforschung. 1997. PMID: 9037440

2

Disposition of the new angiotensin II receptor antagonist candesartan cilexetil in rats and dogs.

Kondo T, Yoshida K, Yoshimura Y, Motohashi M, Tanayama S. Kondo T, et al. Among authors: tanayama s. Arzneimittelforschung. 1996 Jun;46(6):594-600. Arzneimittelforschung. 1996. PMID: 8767349

3

Studies on the metabolism of the new antidiabetic agent pioglitazone. Identification of metabolites in rats and dogs.

Kiyota Y, Kondo T, Maeshiba Y, Hashimoto A, Yamashita K, Yoshimura Y, Motohashi M, Tanayama S. Kiyota Y, et al. Among authors: tanayama s. Arzneimittelforschung. 1997 Jan;47(1):22-8. Arzneimittelforschung. 1997. PMID: 9037439

4

Disposition of the new antirheumatic agent ethyl 4-(3,4-dimethoxyphenyl)- 6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate (TAK-603) in rats and dogs.

Tagawa Y, Kiyota Y, Yoshimura Y, Motohashi M, Tanayama S. Tagawa Y, et al. Among authors: tanayama s. Arzneimittelforschung. 1998 Jul;48(7):750-7. Arzneimittelforschung. 1998. PMID: 9706376

5

Enantioselective pharmacokinetics in animals of pazinaclone, a new isoindoline anxiolytic, and its active metabolite.

Kondo T, Yoshida K, Yoshimura Y, Tanayama S. Kondo T, et al. Among authors: tanayama s. Biopharm Drug Dispos. 1995 Dec;16(9):755-73. doi: 10.1002/bdd.2510160906. Biopharm Drug Dispos. 1995. PMID: 8580400

6

Characterization of conjugated metabolites of a new angiotensin II receptor antagonist, candesartan cilexetil, in rats by liquid chromatography/electrospray tandem mass spectrometry following chemical derivatization.

Kondo T, Yoshida K, Yoshimura Y, Motohashi M, Tanayama S. Kondo T, et al. Among authors: tanayama s. J Mass Spectrom. 1996 Aug;31(8):873-8. doi: 10.1002/(SICI)1096-9888(199608)31:8<873::AID-JMS368>3.0.CO;2-J. J Mass Spectrom. 1996. PMID: 8799313

7

Possible factor for nonlinear pharmacokinetics of TAK-603, a new antirheumatic agent, in rats.

Tagawa Y, Miwa K, Yamashita K, Tsukuda R, Yoshimura Y, Tanayama S, Tanigawara Y. Tagawa Y, et al. Among authors: tanayama s. Biopharm Drug Dispos. 1999 Jan;20(1):11-8. doi: 10.1002/(sici)1099-081x(199901)20:1<11::aid-bdd147>3.0.co;2-#. Biopharm Drug Dispos. 1999. PMID: 10086833

8

Effect of its demethylated metabolite on the pharmacokinetics of unchanged TAK-603, a new antirheumatic agent, in rats.

Tagawa Y, Miwa K, Tsukuda R, Yoshimura Y, Tanayama S, Tanigawara Y. Tagawa Y, et al. Among authors: tanayama s. Drug Metab Dispos. 1999 Apr;27(4):495-501. Drug Metab Dispos. 1999. PMID: 10101145

9

Bioactive metabolites of EM574 and EM523, erythromycin derivatives having strong gastrointestinal motor stimulating activity.

Funabashi Y, Maeshiba Y, Inatomi N, Tanayama S, Harada S, Itoh Z, Omura S. Funabashi Y, et al. Among authors: tanayama s. J Antibiot (Tokyo). 1996 Aug;49(8):794-801. doi: 10.7164/antibiotics.49.794. J Antibiot (Tokyo). 1996. PMID: 8823513 Free article.

10

Enantioselective determination of pazinaclone, a new isoindoline anxiolytic, and its active metabolite in rat plasma by high-performance liquid chromatography.

Kondo T, Hamasaki K, Yamaguchi M, Aoki I, Yoshida K, Yoshimura Y, Tanayama S. Kondo T, et al. Among authors: tanayama s. J Chromatogr B Biomed Appl. 1995 Apr 21;666(2):291-7. doi: 10.1016/0378-4347(94)00574-o. J Chromatogr B Biomed Appl. 1995. PMID: 7633605

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters